SCHEMBL19951612

SCHEMBL19951612

FNc1ccc(Br)c(OC(F)F)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 1/20 0.34
▸ MAPT P10636 12/20 0.33
▸ MEN1 O00255 11/20 0.33
▸ KMT2A Q03164 11/20 0.33
▸ HTT P42858 8/20 0.33
▸ ALDH1A1 P00352 6/20 0.33
▸ MBOAT4 Q96T53 1/20 0.33
▸ LMNA P02545 9/20 0.33
▸ SMN1; SMN2 Q16637 5/20 0.33
▸ TP53 P04637 2/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ HTR1E P28566 1/20 0.33
▸ S1PR3 Q99500 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ RAB9A P51151 2/20 0.31
▸ NPSR1 Q6W5P4 2/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ NFKB1 P19838 1/20 0.31
▸ NFKB2 Q00653 1/20 0.31
▸ RELA Q04206 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19458942 0.76 MAPK1 (0.41) RXRAMAPTMEN1KMT2AHTT
SCHEMBL25368387 0.75 ALOX15 (0.43) RXRAMAPTMEN1KMT2AHTT
SCHEMBL3819565 0.75 RXRA (0.41) RXRAMEN1KMT2AHTTALDH1A1
SCHEMBL30019983 0.75 RXRA (0.41) RXRAMEN1KMT2AHTTALDH1A1
SCHEMBL2723642 0.74 EPHX2 (0.39) MAPTALDH1A1L3MBTL1POLBGAA
SCHEMBL14018146 0.73 L3MBTL1 (0.39) RXRAMAPTMEN1KMT2AHTT
SCHEMBL19606074 0.73 ALDH1A1 (0.44) RXRAMAPTMEN1KMT2AHTT
SCHEMBL31342255 0.73 RXRA (0.35) RXRAMBOAT4
SCHEMBL16899381 0.73 MBOAT4 (0.39) RXRAMAPTMEN1KMT2AHTT
SCHEMBL17711299 0.73 RXRA (0.35) RXRAMBOAT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3510032-A1 PYRAZOLOPYRIDINE DERIVATIVES AS HPK1 MODULATORS AND USES THEREOF FOR THE TREATMENT OF CANCER Incyte Corporation (US) 2019-07-17 — — EP disclosed
WO-2018049200-A1 PYRAZOLOPYRIDINE DERIVATIVES AS HPK1 MODULATORS AND USES THEREOF FOR THE TREATMENT OF CANCER INCYTE CORPORATION (US) 2018-03-15 — — WO disclosed
Send feedback